• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌6号染色体缺失的高分辨率图谱

High resolution mapping of chromosome 6 deletions in cervical cancer.

作者信息

Mazurenko N, Attaleb M, Gritsko T, Semjonova L, Pavlova L, Sakharova O, Kisseljov F

机构信息

Division of Tumor Transforming Genes, Institute of Carcinogenesis, Blokhin Cancer Research Center, 115478 Moscow, Russia.

出版信息

Oncol Rep. 1999 Jul-Aug;6(4):859-63. doi: 10.3892/or.6.4.859.

DOI:10.3892/or.6.4.859
PMID:10373671
Abstract

Chromosome 6 is frequently affected in different tumors. However, little information exists on chromosome 6 deletions in cervical cancer. We have studied loss of heterozygosity (LOH) and microsatellite instability (MIN) in 62 invasive squamous cell carcinomas of the cervix (CC) using 19 polymorphic microsatellite markers spanning both arms of chromosome 6 and one marker located at 5p15. We found that LOH at chromosome 6 is a common feature of cervical carcinomas: 90% (56/62) of CC had LOH at least at one locus and about 58% (36/62) had LOH on both arms of chromosome 6. The highest LOH incidence was shown in HLA region (6p21.3-6p21.1) with markers D6S273 and D6S276 in 52.7% and 45.2% of informative cases respectively. Frequent LOH on 6q was found at loci D6S311 (6q24-25. 1), D6S305 (6q26) and D6S281 (6q27-6qter) in 37.8%, 33.3% and 39.0% of informative cases respectively. There was no significant correlation observed between clinical parameters of cervical cancer (age, histologic grade, clinical stages and progression) and LOH frequency. Microsatellite instability was found in 3 out of 62 cases (4.8%) at three and more loci out of 20 tested. The study shows that several regions on 6p and 6q may harbour potential tumor-suppressor genes important for cervical cancer progression.

摘要

6号染色体在不同肿瘤中经常受到影响。然而,关于宫颈癌中6号染色体缺失的信息却很少。我们使用19个多态性微卫星标记物(覆盖6号染色体的两条臂)和一个位于5p15的标记物,研究了62例宫颈浸润性鳞状细胞癌(CC)中的杂合性缺失(LOH)和微卫星不稳定性(MIN)。我们发现,6号染色体上的LOH是宫颈癌的一个常见特征:90%(56/62)的CC至少在一个位点存在LOH,约58%(36/62)在6号染色体的两条臂上都存在LOH。在HLA区域(6p21.3 - 6p21.1),标记物D6S273和D6S276的LOH发生率最高,分别在52.7%和45.2%的信息性病例中出现。在6q上,标记物D6S311(6q24 - 25.1)、D6S305(6q26)和D6S281(6q27 - 6qter)的LOH在37.8%、33.3%和39.0%的信息性病例中频繁出现。在宫颈癌的临床参数(年龄、组织学分级、临床分期和进展)与LOH频率之间未观察到显著相关性。在62例病例中有3例(4.8%)在20个检测位点中的三个及以上位点发现微卫星不稳定性。该研究表明,6p和6q上的几个区域可能含有对宫颈癌进展至关重要的潜在肿瘤抑制基因。

相似文献

1
High resolution mapping of chromosome 6 deletions in cervical cancer.宫颈癌6号染色体缺失的高分辨率图谱
Oncol Rep. 1999 Jul-Aug;6(4):859-63. doi: 10.3892/or.6.4.859.
2
[Loss of heterozygosity at chromosome 6 as a marker of early genetic alterations in cervical intraepithelial neoplasias and microinvasive carcinomas].6号染色体杂合性缺失作为宫颈上皮内瘤变和微浸润癌早期基因改变的标志物
Mol Biol (Mosk). 2006 May-Jun;40(3):436-47.
3
Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.子宫颈癌中3号、11号和17号染色体特定区域杂合性缺失。
Br J Cancer. 1998;77(2):192-200. doi: 10.1038/bjc.1998.33.
4
Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.6号染色体p21.2区域杂合性缺失作为人宫颈癌放疗后复发的潜在标志物。
Clin Cancer Res. 2000 Mar;6(3):1079-85.
5
[Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].[应用微卫星分析技术对喉鳞状细胞癌9p13-23杂合性缺失的精细定位及临床意义研究]
Ai Zheng. 2003 May;22(5):452-7.
6
Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma.1号染色体上的等位基因缺失与宫颈癌的肿瘤进展相关。
Cancer. 1999 Oct 1;86(7):1294-8.
7
Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.宫颈癌中的基因组改变:染色体杂合性缺失与人乳头瘤病毒肿瘤状态
Cancer Res. 1996 Jan 1;56(1):197-205.
8
HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中HLA I类分子表达及6号染色体短臂和15号染色体长臂的染色体缺失
Tissue Antigens. 1999 Sep;54(3):235-45. doi: 10.1034/j.1399-0039.1999.540304.x.
9
Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.子宫颈微切割腺癌及原位腺癌中3号染色体短臂和6号染色体长臂的杂合性缺失
Cancer. 2002 Feb 1;94(3):793-802. doi: 10.1002/cncr.10275.
10
Allelic deletion mapping on chromosome 6q and X chromosome inactivation clonality patterns in cervical intraepithelial neoplasia and invasive carcinoma.6号染色体长臂上等位基因缺失定位以及宫颈上皮内瘤变和浸润性癌中的X染色体失活克隆模式
Gynecol Oncol. 2001 Mar;80(3):364-71. doi: 10.1006/gyno.2000.6087.

引用本文的文献

1
Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.基于下一代测序技术的宫颈癌基因组特征分析。
Genes (Basel). 2022 Jan 31;13(2):287. doi: 10.3390/genes13020287.
2
Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the II Locus in HIV-1/HPV Co-infected Women.对HIV-1/HPV合并感染女性的宫颈肿瘤活检样本进行研究,检测II位点的杂合性缺失(LOH)和微卫星不稳定性(MSI)。
Front Oncol. 2019 Oct 15;9:951. doi: 10.3389/fonc.2019.00951. eCollection 2019.
3
Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade.
SOX2+ 垂体干细胞的稳态和致瘤活性受 LATS/YAP/TAZ 级联的控制。
Elife. 2019 Mar 26;8:e43996. doi: 10.7554/eLife.43996.
4
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.LATS1 和 LATS2 肿瘤抑制因子:超越 Hippo 通路。
Cell Death Differ. 2017 Sep;24(9):1488-1501. doi: 10.1038/cdd.2017.99. Epub 2017 Jun 23.
5
p31(comet) inactivates the chemically induced Mad2-dependent spindle assembly checkpoint and leads to resistance to anti-mitotic drugs.p31(彗星蛋白)使化学诱导的Mad2依赖的纺锤体组装检查点失活,并导致对抗有丝分裂药物产生抗性。
Springerplus. 2013 Oct 25;2:562. doi: 10.1186/2193-1801-2-562. eCollection 2013.
6
Decreased expression of LATS1 is correlated with the progression and prognosis of glioma.LATS1 表达降低与胶质瘤的进展和预后相关。
J Exp Clin Cancer Res. 2012 Aug 21;31(1):67. doi: 10.1186/1756-9966-31-67.
7
Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.热休克蛋白 90 抑制会耗尽 LATS1 和 LATS2,这两种蛋白是哺乳动物 hippo 肿瘤抑制途径的调节因子。
Cancer Res. 2010 Nov 1;70(21):8642-50. doi: 10.1158/0008-5472.CAN-10-1345. Epub 2010 Sep 14.
8
Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.宫颈癌中 6q25-27 等位基因缺失,PARKIN 肿瘤抑制基因座。
Med Oncol. 2011 Dec;28(4):1520-6. doi: 10.1007/s12032-010-9633-x. Epub 2010 Jul 22.
9
Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.低LATS2信使核糖核酸水平可预测乳腺癌患者对表柔比星加环磷酰胺治疗有良好反应,但对多西他赛治疗则不然。
J Cancer Res Clin Oncol. 2007 Aug;133(8):501-9. doi: 10.1007/s00432-007-0194-0. Epub 2007 Feb 13.
10
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.新型ETS因子TEL2在B淋巴细胞瘤发生过程中与Myc协同作用。
Mol Cell Biol. 2005 Mar;25(6):2395-405. doi: 10.1128/MCB.25.6.2395-2405.2005.